academic article

• Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. 2016
• A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment..  The pharmacogenomics journal.  :-. 2016
• A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults. 2015
• Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia..  Nature communications.  6:-. 2015
• Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. 2014
• ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  30:751-757. 2012
• Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia..  Blood.  120:4197-4204. 2012
• Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia..  Nature genetics.  43:237-241. 2011
• Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group..  Blood.  118:3080-3087. 2011
• Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome..  Blood.  116:4874-4884. 2010
• Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia..  The New England journal of medicine.  360:470-480. 2009
• Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia..  JAMA.  301:393-403. 2009
• Germline genomic variants associated with childhood acute lymphoblastic leukemia..  Nature genetics.  41:1001-1005. 2009